http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102400884-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54 |
filingDate | 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102400884-B1 |
titleOfInvention | Fusion protein comprising modified interleukin-7 and interleukin-2 and use thereof |
abstract | The present invention relates to a fusion protein comprising modified interleukin-7 and interleukin-2 and uses thereof. The fusion protein comprising the modified IL-7 and IL-2 of the present invention has a high production yield, induces differentiation of cytotoxic T cells, and can promote proliferation. In addition, the fusion protein of the present invention can promote the differentiation of NK cells and effectively inhibit cancer. Therefore, the fusion protein of the present invention can be usefully used for the treatment of cancer or infectious diseases. |
priorityDate | 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 673.